Validation of Dozee, a Ballistocardiography-based Device, for Contactless and Continuous Heart Rate and Respiratory Rate Measurement

Long-term acquisition of respiratory and heart signals is useful in a variety of applications, including sleep analysis, monitoring of respiratory and heart disorders, and so on. Ballistocardiography (BCG), a non-invasive technique that measures micro-body vibrations caused by cardiac contractions as well as motion caused by breathing, snoring, and body movements, would be ideal for long-term vital parameter acquisition. Turtle Shell Technologies Pvt. Ltd.'s Dozee device, which is based on BCG, is a contactless continuous vital parameters monitoring system. It is designed to measure Heart Rate (HR) and Respiratory Rate (RR) continuously and without contact in a hospital setting or at home. A validation study for HR and RR was conducted using Dozee by comparing it to the vitals obtained from the FDA-approved Patient Monitor. This was done in a sleep laboratory setting over 110 nights in 51 subjects to evaluate HR and over 20 nights in 17 subjects to evaluate RR at the National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India. Approximately 789 hours data for HR and approximately 112 hours data for RR was collected. Dozee was able to achieve a mean absolute error of 1.72 bpm for HR compared to the gold standard ECG. A mean absolute error of similar to 1.24 breaths/min was obtained in determining RR compared to currently used methods. Dozee is ideal for long-term contactless monitoring of vital parameters due to its low mean absolute errors in measuring both HR and RR.